Search

everythinglearnresearchcommunity

for

Search:↓

Ipilimumab can cause various adverse events in elderly patients, especially affecting the gastrointestinal and endocrine systems.

Tacrolimus treatment for autoimmune hepatitis can cause hair loss.

Upadacitinib effectively treats psoriasiform eczema and some related conditions.

Selective immunotherapies like anifrolumab and belimumab are more effective for treating systemic lupus erythematosus than traditional drugs.

UTMD with diclofenac and Doxil® improves cancer treatment by boosting immune response and reducing tumor-supporting cells.

Azathioprine can help with relapses and disability in NMOSD but has more side effects and needs more research.

Teriflunomide is safe and tolerable for treating relapsing-remitting multiple sclerosis, with manageable side effects.

Azathioprine caused side effects in over half of the Korean pediatric inflammatory bowel disease patients, requiring close monitoring.

High-dose IV iron is safe and effective for treating anaemia in IBD patients.

Tacrolimus causes fewer acute rejections than cyclosporin A in kidney transplants but doesn't necessarily improve kidney function after one year; cardiovascular risks and side effects vary between the two drugs.

A humanized IL-2 fusion protein boosts T regulatory cells and helps control hair loss in Alopecia Areata.

Ivarmacitinib significantly improved hair regrowth in severe alopecia areata after tofacitinib was less effective.

A woman with inflammatory bowel disease improved after treatment with ustekinumab for a rare skin condition associated with her disease.

MTX and GC combinations are the most effective for early rheumatoid arthritis.

Safusidenib erbumine shows promise as a treatment for certain brain tumors, but mild side effects like hair loss need attention.

A patient with advanced kidney cancer and no hepatitis C developed skin inflammation due to a drug called interferon alpha-2a.

M50054 may help treat hepatitis and hair loss from chemotherapy.

A kidney transplant and immunosuppressive treatment stopped the skin disease in a patient.

The choice between belimumab and anifrolumab depends on the specific symptoms of the patient's lupus.

Certain medications can cause serious side effects, so it's important to report them.

Anifrolumab may help improve symptoms in patients with overlapping autoimmune diseases.

Oral cyclosporine A and prednisolone effectively improved alopecia universalis without side effects.

Both azathioprine and betamethasone treatments help with hair regrowth in alopecia areata, but azathioprine may have fewer side effects.

Antihepcidin antibodies may treat inflammation-induced anemia by improving iron metabolism.

Guselkumab effectively treats skin reactions caused by adalimumab in certain conditions.

Almost all kidney transplant patients had complications from immunosuppressive therapy, with excessive hair growth being the most common.

A mother and son both had ulcerative colitis and alopecia, suggesting a genetic link in autoimmune disorders and successful treatment with cyclosporine.

Mogamulizumab can cause hair loss and skin rashes.

ASLAN004 was safe and well-tolerated, supporting further development for treating certain diseases.

Topical tacrolimus is safe and effective for skin conditions, but oral tacrolimus has serious side effects.